Close

Aziyo Biologics (AZYO) Appoints Co-Founder Randy Mills as CEO

August 9, 2022 6:22 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company, today announced that Aziyo co-founder C. Randal (Randy) Mills, Ph.D. has assumed the President and Chief Executive Officer role on an on-going basis. Dr. Mills, who is internationally recognized for his contributions to the field of regenerative medicine, has served as the Company’s interim CEO since June 2022.

“Since creating Aziyo in 2015, Randy and I have worked together to build a company where regenerative medicine is used to its full potential,” said Kevin Rakin, co-founder and executive chairman. “Randy is a visionary leader with a track record of creating significant shareholder value in regenerative medicine. The Board and I look forward to partnering with Randy as we make his vision for this company a reality.”

“We don’t think that 1 in 10 women undergoing breast reconstruction should face serious infection. Nor should a pacemaker wear through the fragile skin of a patient in heart block,” said Dr. Randy Mills, CEO. “We aim to change that. We know the impact regenerative medicine can have on patient’s lives – now it’s our job to make it happen.”

Conference CallFor an update on the company’s second quarter 2022 financial results, performance and vision for the future, please join an enhanced conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Thursday, August 11, 2022. Individuals interested in listening to the conference call are required to register online. Participants are required to register at least 15 minutes before the start of the call. A live and Archived webcast of the event will be available on the “investors” section of the Aziyo website at https://investors.aziyo.com/.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Management Changes

Related Entities

Earnings, IPO